Opaleye Management’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Opaleye Management’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-125,000	Closed	-$5.03M	–	54
2016 Q3	$5.03M	Hold	125,000	–	–	2.63%	10
2016 Q2	$2.09M	Buy	125,000 +4,000	+3%	+$53.8K	1.4%	27
2016 Q1	$1.44M	Buy	121,000 +11,000	+10%	+$147K	0.9%	35
2015 Q4	$1.68M	Buy	110,000 +81,000	+279%	+$1.23M	0.7%	44
2015 Q3	$469K	Buy	+29,000	New	+$471K	0.23%	47

Opaleye Management's CYNA Position: Q4 2016 in Review

Opaleye Management sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 125,000 shares — an estimated $5.03M sold.

Opaleye Management first reported a position in CYNA in Q3 2015 and held it in 5 quarters. The position peaked at $5.03M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

Opaleye Management reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
Opaleye Management sold 125,000 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $5.03M.
Opaleye Management first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2015 and held it in 5 quarters.
Opaleye Management's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $5.03M in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Opaleye Management's 13F filing for Q4 2016, filed 21 Feb 2017.